{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:15:51Z","timestamp":1781100951264,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T00:00:00Z","timestamp":1402617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T00:00:00Z","timestamp":1402617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s10637-014-0127-0","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:49:14Z","timestamp":1402534154000},"page":"1204-1212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-\u03ba\u0392 and p70s6k, in patients with advanced solid tumors"],"prefix":"10.1007","volume":"32","author":[{"given":"D. S.","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Henary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. S.","family":"Falchook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Naing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Moulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Wheler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tsimberidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. B.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,13]]},"reference":[{"key":"127_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/00001813-200106000-00009","volume":"12","author":"S Johansson","year":"2001","unstructured":"Johansson S, Lindholm P, Gullbo J, Larsson R, Bohlin L, Claeson P (2001) Cytotoxicity of digoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs 12:475\u2013483","journal-title":"Anticancer Drugs"},{"issue":"11","key":"127_CR2","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1158\/0008-5472.CAN-05-3544","volume":"66","author":"S Frese","year":"2006","unstructured":"Frese S, Free-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA (2006) Cardia glycosides initiate Apo2L\/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Cancer Res 66(11):5867\u20135874","journal-title":"Cancer Res"},{"key":"127_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0304-3835(02)00263-X","volume":"185","author":"S Nasu","year":"2002","unstructured":"Nasu S, Milas L, Kawabe S, Raju U, Newman RA (2002) Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process. Cancer Lett 185:145\u2013151","journal-title":"Cancer Lett"},{"issue":"14","key":"127_CR4","first-page":"3807","volume":"60","author":"DJ McConkey","year":"2000","unstructured":"McConkey DJ, Lin Y, Nutt LK, Ozel HZ, Newman RA (2000) Cardiac glycosides stimulate Ca increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res 60(14):3807\u20133812","journal-title":"Cancer Res"},{"key":"127_CR5","first-page":"49","volume":"2","author":"B Stenkvist","year":"1980","unstructured":"Stenkvist B, Benatsson E, Eklund G et al (1980) Evidence of a modifying effect of heart glycosides on the development of breast cancer. Anal Quant Cytol Histol 2:49\u201354","journal-title":"Anal Quant Cytol Histol"},{"issue":"6","key":"127_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1054\/mehy.1999.0985","volume":"53","author":"J Haux","year":"1999","unstructured":"Haux J (1999) Digitoxin is a potential anticancer agent for several types of cancer. Med Hypotheses 53(6):543\u2013548","journal-title":"Med Hypotheses"},{"key":"127_CR7","first-page":"493","volume":"6","author":"B Stenkvist","year":"1999","unstructured":"Stenkvist B (1999) Is digitalis a therapy for breast carcinoma? Oncol Rep 6:493\u2013496","journal-title":"Oncol Rep"},{"key":"127_CR8","doi-asserted-by":"crossref","unstructured":"Smith JA, Madden T, Vijjeswarapu M, Newman RA (2001) Inhibition of export of FGF-2 from the prostate cancer cell lines PC3 and DU 145 by Anvirzel and its cardiac glycoside component oleandrin. Biochem. Pharmacol. 62(4): 469\u2013472.","DOI":"10.1016\/S0006-2952(01)00690-6"},{"key":"127_CR9","first-page":"3838","volume":"60","author":"SK Manna","year":"2000","unstructured":"Manna SK, Sah NK, Newman RA, Cisneros A, Aggarwal BB (2000) Oleandrin suppresses activation of nuclear transcription factor- kB, activator protein-1 and c-Jun NH2-terminal kinase. Cancer Res 60:3838\u20133847","journal-title":"Cancer Res"},{"issue":"1","key":"127_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1124\/mi.8.1.8","volume":"8","author":"R Newman","year":"2008","unstructured":"Newman R, Yang P, Pawlus A, Block K (2008) Cardiac glycosides as novel cancer therapeutic agents. Mol Interv 8(1):36\u201349. doi:10.1124\/mi.8.1.8","journal-title":"Mol Interv"},{"key":"127_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/1534735407309623","volume":"6","author":"RA Newman","year":"2007","unstructured":"Newman RA, Kondo Y, Yokoyama T, Dixon S, Cartwright C, Chan D, Johansen M, Yang P (2007) Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside. Integr Cancer Ther 6:354\u2013364","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"127_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10875-006-9028-0","volume":"26","author":"Y Sreenivason","year":"2006","unstructured":"Sreenivason Y, Raghavendra PB, Manna SK (2006) Oleandrin-mediated expression of Fas potentiates apoptosis in tumor cells. J Clin Immunol 26(4):308\u2013322","journal-title":"J Clin Immunol"},{"key":"127_CR13","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.molimm.2006.11.009","volume":"44","author":"PB Raghavendra","year":"2007","unstructured":"Raghavendra PB, Sreenivasan Y, Manna SK (2007) Oleandrin induces apoptosis in human, but not in murine cells: dephosphorylation of Akt, expression of FasL, and alteration of membrane fluidity. Mol Immunol 44:2292\u20132302","journal-title":"Mol Immunol"},{"key":"127_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s000660050055","volume":"176","author":"FA Verheye-Dua","year":"2000","unstructured":"Verheye-Dua FA, Bohm L (2000) Influence of apoptosis on the enhancement of radiotoxicity by ouabain. Strahlenther Onkol 176:186\u2013191","journal-title":"Strahlenther Onkol"},{"key":"127_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/(SICI)1520-6823(1998)6:3<109::AID-ROI1>3.0.CO;2-1","volume":"6","author":"F Verheye-Dua","year":"1998","unstructured":"Verheye-Dua F, Bohm L (1998) Na+, K\u2009+\u2009\u2212ATPase inhibitor, ouabain accentuates irradiation damage in human tumour cell lines. Radiat Oncol Investig 6:109\u2013119","journal-title":"Radiat Oncol Investig"},{"issue":"5","key":"127_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10637-006-7772-x","volume":"24","author":"T Mekhail","year":"2006","unstructured":"Mekhail T, Kaur H, Ganapathi R, Budd GT, Elson P, Bukowski RM (2006) Phase I trial of Anvirzel in patients with refractory solid tumors. Invest New Drugs 24(5):423\u20137","journal-title":"Invest New Drugs"},{"key":"127_CR17","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE), http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html"},{"key":"127_CR18","doi-asserted-by":"publisher","first-page":"W221","DOI":"10.2214\/AJR.09.3928","volume":"195","author":"M Nishino","year":"2010","unstructured":"Nishino M, Jagannathan JP, Ramaiya NH, Van den Abbeele AD (2010) New response evaluation criteria in solid tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. AJR Am J Roentgenol 195:W221\u20138","journal-title":"AJR Am J Roentgenol"},{"key":"127_CR19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/0959-8049(95)00664-8","volume":"32A","author":"G Buccheri","year":"1996","unstructured":"Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A:1135\u201341","journal-title":"Eur J Cancer"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-014-0127-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-014-0127-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-014-0127-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-014-0127-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:55:12Z","timestamp":1678510512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-014-0127-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,13]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s10637-014-0127-0","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,13]]},"assertion":[{"value":"14 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}